IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC

© European Society for Medical Oncology 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: Chemotherapy remains the mainstay therapy for metastatic triple-negat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Emens, Leisha Ann (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 December 2016
In: Annals of oncology
Year: 2016, Jahrgang: 27
ISSN:1569-8041
DOI:10.1016/S0923-7534(21)00294-5
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/S0923-7534(21)00294-5
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753421002945
Volltext
Verfasserangaben:L. Emens, S. Adams, S. Loi, A. Schneeweiss, H. Rugo, E. Winer, C. Barrios, V. Dieras, J. de la Haba-Rodriguez, L. Gianni, N. Kusuma, S.Y. Chui, P. Schmid

MARC

LEADER 00000caa a2200000 c 4500
001 1563389622
003 DE-627
005 20240927095509.0
007 cr uuu---uuuuu
008 170911s2016 xx |||||o 00| ||eng c
024 7 |a 10.1093/annonc/mdw577.019  |2 doi 
035 |a (DE-627)1563389622 
035 |a (DE-576)493389628 
035 |a (DE-599)BSZ493389628 
035 |a (OCoLC)1340979231 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Emens, Leisha Ann  |e VerfasserIn  |0 (DE-588)1139674196  |0 (DE-627)897410122  |0 (DE-576)493389598  |4 aut 
245 1 0 |a IMpassion130  |b Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC  |c L. Emens, S. Adams, S. Loi, A. Schneeweiss, H. Rugo, E. Winer, C. Barrios, V. Dieras, J. de la Haba-Rodriguez, L. Gianni, N. Kusuma, S.Y. Chui, P. Schmid 
264 1 |c 20 December 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.09.2017 
520 |a © European Society for Medical Oncology 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: Chemotherapy remains the mainstay therapy for metastatic triple-negative breast cancer (mTNBC) but offers limited clinical benefit at the expense of significant toxicity. This underscores the need for new treatment options. Atezolizumab (atezo) is a mAb specific for PD-L1 that prevents PD-L1 binding to its receptors PD-1 and B7.1, thereby restoring tumor-specific T-cell immunity. TNBC is a rational target indication for atezo due to PD-L1 expression on tumor-infiltrating immune cells (IC), and a high mutation burden that may generate immunogenic neoantigens. Atezo monotherapy was well tolerated and produced durable responses in patients (pts) with mTNBC (Emens et al 2015). Promising activity observed in pts treated with atezo plus nab-paclitaxel (nab-pac) supports the hypothesis that the combination may represent an effective new... 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
773 0 8 |i Enthalten in  |t Annals of oncology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 27(2016,Supplement 9) Artikel-Nummer 136TiP, 1 Seite  |h Online-Ressource  |w (DE-627)320428796  |w (DE-600)2003498-2  |w (DE-576)098134345  |x 1569-8041  |7 nnas  |a IMpassion130 Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC 
773 1 8 |g volume:27  |g year:2016  |g supplement:Supplement 9  |a IMpassion130 Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC 
856 4 0 |u https://doi.org/10.1016/S0923-7534(21)00294-5  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0923753421002945  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20170911 
993 |a Article 
994 |a 2016 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |e 910000PS109972554  |k 0/910000/  |p 4 
999 |a KXP-PPN1563389622  |e 2980009407 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"subtitle":"Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC","title_sort":"IMpassion130","title":"IMpassion130"}],"language":["eng"],"note":["Gesehen am 11.09.2017"],"recId":"1563389622","type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"disp":"IMpassion130 Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBCAnnals of oncology","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Annals of oncology","title_sort":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology"}],"language":["eng"],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"European Society for Medical Oncology"}],"recId":"320428796","type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"1990","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedDisp":"1990-"}],"id":{"issn":["1569-8041"],"eki":["320428796"],"zdb":["2003498-2"]},"pubHistory":["1.1990 -"],"part":{"volume":"27","year":"2016","text":"27(2016,Supplement 9) Artikel-Nummer 136TiP, 1 Seite"}}],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"20 December 2016"}],"id":{"doi":["10.1093/annonc/mdw577.019"],"eki":["1563389622"]},"name":{"displayForm":["L. Emens, S. Adams, S. Loi, A. Schneeweiss, H. Rugo, E. Winer, C. Barrios, V. Dieras, J. de la Haba-Rodriguez, L. Gianni, N. Kusuma, S.Y. Chui, P. Schmid"]},"person":[{"role":"aut","roleDisplay":"VerfasserIn","family":"Emens","given":"Leisha Ann","display":"Emens, Leisha Ann"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Andreas","family":"Schneeweiss","display":"Schneeweiss, Andreas"}]} 
SRT |a EMENSLEISHIMPASSION12020